Viewing Study NCT01100060


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-02-04 @ 9:02 AM
Study NCT ID: NCT01100060
Status: COMPLETED
Last Update Posted: 2010-08-25
First Post: 2010-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
Sponsor: Pfizer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A0661195
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Director, Clinical Trial Disclosure Group
Old Organization: Pfizer, Inc.

Collaborators